TICKERNERD
Menu
HCAHCAHealthcare · Medical Care Facilities

HCA Stock Forecast: HCA Healthcare, Inc. Price Predictions for 2026-2027

Last close, 14 Oct 2026
$470
+2.10% on the day

The 26 Wall Street analysts covering HCA Healthcare, Inc. hold a median 12-month price target of $476 — +1.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 71 of 100 as at 14 Oct 2026 — in the upper half. Here, the model and the Street point the same way.

Market cap
$99.3B
Ticker Nerd rank
71 / 100
Median analyst target
$476
Analysts covering
26
Revenue$20.2B+8.7% y/y
Operating income$3.1B
Net income$1.9B
Free cash flow$1.1B
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+7.1%
1M
+10.8%
YTD
+1.3%
1Y
+13.2%
From 52W high
−13.2%
From 52W low
+30.7%
$360
$542
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

HCA stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores HCA Healthcare, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Oct 2026
71 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
91
Volatility
86
Value
83
Growth
77
Issuance
60
Momentum
58
Accruals
52
Revisions
49
Size
3

Quality (91): The business earns solid, repeatable profits on what it owns.

Revisions (49): Analysts have, on balance, been cutting their forecasts.

Size (3): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

HCA stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HCA, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$350$400$450$500$550$600Jan 26Apr 26Jul 26Oct 26HCAHigh $579Median $476Low $380

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says26 analysts
15 Buy10 Hold1 Sell
Low $380Median $476High $579

The green dot is the last close — the median target sits +1.1% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 3 moved their price target up and 5 moved it down.

DateFirmActionRatingTarget
12 Oct 2026TD CowenMaintainsBuy$431 → $460
7 Oct 2026RBC CapitalMaintainsOutperform$435 → $496
23 Sept 2026BMO CapitalInitiatesOutperform—
23 Sept 2026BMO CapitalInitiatesOutperform$495
18 Sept 2026Leerink PartnersMaintainsOutperform$492
18 Sept 2026Leerink PartnersMaintainsOutperform—
8 Sept 2026RBC CapitalReiteratesOutperform—
8 Sept 2026RBC CapitalReiteratesOutperform$435
20 Aug 2026JP MorganMaintainsNeutral$490 → $425
20 Aug 2026JP MorganMaintainsNeutral—
3 Aug 2026Wells FargoMaintainsEqual-Weight—
3 Aug 2026Wells FargoMaintainsEqual-Weight$369 → $381
28 July 2026Goldman SachsMaintainsBuy—
28 July 2026Goldman SachsMaintainsBuy$558 → $485
28 July 2026MizuhoMaintainsOutperform—
28 July 2026MizuhoMaintainsOutperform$525 → $475
27 July 2026BairdMaintainsNeutral—
27 July 2026BairdMaintainsNeutral$396 → $393
27 July 2026BarclaysMaintainsEqual-Weight$402 → $387
27 July 2026BarclaysMaintainsEqual-Weight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HCA appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

HCA vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Oct 2026, HCA Healthcare, Inc. returned +13.2% against +17.5% for the S&P 500, dividends included.

HCA vs S&P 500, last 12 monthsTotal return, rebased to 100
8090100110120130Jan 26Apr 26Jul 26Oct 26HCAS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

HCA analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−2.4%
Analysts raising
0
Analysts cutting
3
Fundamentals

HCA Healthcare, Inc. (HCA) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
15.4×

Cheaper than 44% of US stocks

Price / sales
1.3×

Cheaper than 63% of US stocks

Price / book
−31.1×

Cheaper than 99% of US stocks

EV / EBITDA
9.7×

Cheaper than 38% of US stocks

Growth & margins
Revenue growth (YoY)
8.7%

Higher than 48% of US stocks

Earnings growth (YoY)
2.8%

Higher than 39% of US stocks

Gross margin
44.8%

Higher than 55% of US stocks

Operating margin
15.2%

Higher than 73% of US stocks

Net margin
8.8%

Higher than 67% of US stocks

Returns & dividend
Return on equity
−244.8%

Higher than 6% of US stocks

Return on assets
12.3%

Higher than 95% of US stocks

Dividend yield
0.7%

Higher than 67% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

HCA Healthcare, Inc. (HCA) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • HCA Healthcare, Inc. has a market value of $99.3B and an enterprise value of $153.1B.

  • Revenue in the twelve months to 30 June 2026: $78.0B. The latest quarter grew 8.7% year on year.

  • Net income over the same four quarters: $7.9B, a 10.1% net margin.

  • Diluted earnings per share, trailing twelve months: $29.87.

  • Free cash flow in the twelve months to 30 June 2026: $6.0B.

  • HCA Healthcare, Inc. spent $8.7B on share buybacks and $682.0M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 218.0M.

  • Trailing P/E: 15.4×; forward P/E: 14.3× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.68%, paying out 10% of earnings.

  • HCA Healthcare, Inc. employs 230,000 people — $339K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 13 Oct 2026

Data provided by Twelve Data

Peers

HCA vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
HCAHCA Healthcare, Inc.$99.3B
71
THCTenet Healthcare Corp.$21.9B
97
EHCEncompass Health Corp.$12.6B
83
DVADaVita, Inc.$12.1B
93
UHSUniversal Health Services, Inc.$11.0B
69
ENSGThe Ensign Group, Inc.$10.2B
61
PACSPACS Group, Inc.$7.1B
88

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own HCA Healthcare, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest HCA news & analysis

HCA Healthcare Is Too Healthy To Downgrade

Seeking Alpha · 13 Oct 2026positive

Seeking Alpha maintains a “Buy” view on HCA, citing revenue growth, favorable healthcare-demand demographics, higher revenue per equivalent admission, and improved occupancy. It notes payer-mix-related margin pressure and slightly lower net income and EBITDA guidance alongside management’s 2026 revenue outlook of $77–$79.5 billion.

Why it matters — HCA watchers may weigh continued revenue and occupancy gains against margin pressures and reduced earnings guidance.

Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus

Zacks Investment Research · 12 Oct 2026neutral

Zacks Investment Research reports that HF Sinclair, Accenture and FirstCash posted gains, with Zacks research portfolios highlighting these performers amid market uncertainty and shifting investor sentiment.

Why it matters — The item does not discuss HCA Healthcare or provide company-specific information relevant to HCA watchers.

Top 50 High-Quality Dividend Growth Stocks For October 2026

Seeking Alpha · 11 Oct 2026neutral

Seeking Alpha tracks 50 high-quality dividend growth stocks for October 2026, assessing entry points by valuation and future return potential. It reports ranking improvements for Applied Materials, D.R. Horton, and Home Depot, with 44 stocks showing forward return estimates of at least 10% and 32 potentially undervalued by free cash flow mean reversion.

Why it matters — The excerpt does not mention HCA Healthcare, so it provides no company-specific information for HCA watchers.

HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call

Business Wire · 30 Sept 2026neutral

HCA Healthcare, Inc. announced that it will hold its third quarter 2026 earnings conference call on Tuesday, October 27, 2026, at 9:00 AM Central Time, with a live audio webcast available via the company's investor relations website and a replay for those unable to listen live.

Why it matters — HCA watchers would care because the scheduled call provides the date and access details for the company's upcoming third-quarter financial results and management commentary.

HCA Healthcare Presents 2026 Awards of Distinction

Business Wire · 29 Sept 2026positive

HCA Healthcare presented its annual Awards of Distinction at a ceremony in Nashville, Tennessee. The awards, which include the Frist Humanitarian Award and the Excellence in Nursing Award, are the organization's highest honors recognizing colleagues, nurses, physicians and volunteers who exemplify its culture.

Why it matters — The recognition of employees and caregivers highlights positive company culture and workforce engagement, which can support talent retention and operational quality at HCA.

FAQ

Frequently asked questions about HCA stock

What is the HCA stock price forecast for 2026-2027?

The 26 Wall Street analysts covering HCA Healthcare, Inc. have a median 12-month price target of $476, with estimates ranging from $380 to $579. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is HCA stock a buy right now?

Of the 26 analysts covering HCA Healthcare, Inc., 15 rate it a Buy, 10 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks HCA Healthcare, Inc. 71 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank HCA?

As at 14 Oct 2026, HCA Healthcare, Inc. ranks 71 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (91 of 100).

Will HCA stock go up?

No one can know that. What the data says: the median 12-month target from 26 analysts implies +1.1% from the last close, and Ticker Nerd's factor model ranks HCA Healthcare, Inc. 71 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the HCA stock forecast for 2030?

No analyst covering HCA Healthcare, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HCA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $380 to $579 over the next 12 months.

How has HCA stock performed over the past year?

HCA Healthcare, Inc. returned +13.2% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does HCA Healthcare, Inc. do?

HCA Healthcare, Inc. is a healthcare services company that operates a broad network of hospitals, ambulatory surgery centers, freestanding emergency rooms, urgent care clinics, physician practices, diagnostic and imaging centers, rehabilitation facilities, and other care sites.

What is the latest news on HCA?

The most recent item we track (Seeking Alpha, 13 Oct 2026): "HCA Healthcare Is Too Healthy To Downgrade". Seeking Alpha maintains a “Buy” view on HCA, citing revenue growth, favorable healthcare-demand demographics, higher revenue per equivalent admission, and improved occupancy. It notes payer-mix-related margin pressure and slightly lower net income and EBITDA guidance alongside management’s 2026 revenue outlook of $77–$79.5 billion.

Company

About HCA Healthcare, Inc.

HCA Healthcare, Inc. is a healthcare services company that operates a broad network of hospitals, ambulatory surgery centers, freestanding emergency rooms, urgent care clinics, physician practices, diagnostic and imaging centers, rehabilitation facilities, and other care sites. The company serves patients across the United States and the United Kingdom, with a strong emphasis on general and acute care, outpatient services, and specialty care such as oncology and rehabilitation. HCA Healthcare also provides home health and hospice services in select markets, supporting care across multiple stages of treatment. As one of the largest private operators in the hospital sector, HCA Healthcare plays a central role in delivering integrated medical care through coordinated local facilities and physician relationships. Founded in 1968 and headquartered in Nashville, Tennessee, HCA Healthcare focuses on expanding access to community-based healthcare services through its diversified clinical network.

CEO Mr. Samuel N. Hazen · 230,000 employees · United States · https://www.hcahealthcare.com